Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 31, 1181-1187, September 1, 1971]
© 1971 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roberts, D.
Right arrow Articles by Loehr, E. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roberts, D.
Right arrow Articles by Loehr, E. V.

Elevation of Thymidylate Synthetase Activity in CCRF-CEM Cells1

DeWayne Roberts and Ellen V. Loehr

St. Jude Children's Research Hospital, Memphis, Tennessee 38101 [D. R. E. V. L.], and Department of Pharmacology, University of Tennessee Medical Units, Memphis, Tennessee 38103 [D. R.]

The basis for an elevation of thymidylate synthetase activity by methotrexate has been studied with CCRF-CEM cell cultures. In a comparison of oncolytic drug effects on three enzymes from these cells, methotrexate elevated both thymidylate synthetase and thymidine kinase activity but not alanine transaminase activity. The pattern of response by these three enzymes to cytosine arabinoside and hydroxyurea varied from the observations with methotrexate. Cytosine arabinoside and actinomycin D depressed thymidylate synthetase activity. A small but variable response to hydroxyurea was observed. The combination of actinomycin D with methotrexate resulted in a level of thymidylate synthetase activity intermediate between those observed with the individual drugs.

An elevation of thymidylate synthetase activity also occurred in cells from cultures to which substrate or product precursors of the thymidylate synthetase reaction were added. The combination of thymidine or deoxyuridine with methotrexate elevated thymidylate synthetase activity above the level observed with the individual compounds. An in vitro binding of methotrexate to thymidylate synthetase was expressed by an inhibition of enzyme activity.

Folinic acid elevated thymidylate synthetase activity and reversed methotrexate inhibition of growth and of deoxyuridine incorporation into DNA. The methotrexate-induced elevation of thymidylate synthetase activity could be modulated by high concentrations of folinic acid. The elevation of thymidylate synthetase activity by methotrexate, deoxyuridine, thymidine, and folinic acid was attributed to a stabilization of thymidylate synthetase by the formation of enzyme complexes. The predominant phase of the growth cycle of the culture presumably controls the potential for enzyme synthesis, and the action of other drugs on protein synthesis modifies thymidylate synthetase response to methotrexate.

1 Supported by Research Grants CA-11148 and CA-08480 from the National Cancer Institute, NIH, and by American Lebanese Syrian Associated Charities.

Received 2/ 3/71. Accepted 4/20/71.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1971 by the American Association for Cancer Research.